Literature DB >> 21573498

Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.

Bo Ma1, Xia Lei, Yuan Guan, Li-Sha Mou, Yi-Fei Yuan, Han Yue, Yi Lu, Guo-Tong Xu, Jiang Qian.   

Abstract

Previous studies have demonstrated that a small population of cancer stem cell-like cells exists in retinoblastoma. To provide a model for studying this population, we sought to establish a long-term culture from human retinoblastoma that have cancer stem cell-like properties. Fresh tumor tissue was digested and cultured in serum-free medium. Tumor spheres formed and were passaged continuously. Stem cell properties were examined through immunostaining, real-time quantitative RT-PCR and chemoresistance assay. Tumorigenicity of the tumor sphere-forming cells was confirmed by xenograft experiments. Furthermore, we examined the expression of cell surface markers CD44 and CD133. Tumor cells expanded as floating spheres for more than 30 passages. Sphere-forming cells overexpressed stem cell genes Oct‑4, Nestin and Pax6. Immunostaining of spheres showed positivity for Nestin, Pax6 and also ABCG2. In contrast, differentiated cells derived from these spheres expressed high levels of mature retinal cell markers MAP2, GFAP, recoverin, Opsin B and Nrl, and showed immunoreactivity for NF200, GFAP, recoverin and PKCα. Furthermore, both CD44 and CD133 were highly expressed in sphere-forming cells vs. differentiated cells. Sphere-forming cells displayed higher chemoresistance to carboplatin as opposed to differentiated cells. Moreover, intraocular injection of as few as 2x103 sphere-forming cells into NOD/SCID mice gave rise to new tumors similar to the original patient tumors. These results revealed that the sphere-forming cells preserved their stem cell properties and tumorigenicity, even after long-term culture. This would be a suitable in vitro model to study cancer stem-like cells in retinoblastoma and to develop chemotherapeutic drugs and strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573498     DOI: 10.3892/or.2011.1291

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  In vivo molecular imaging of cancer stem cells.

Authors:  Yusri D Heryanto; Arifudin Achmad; Ayako Taketomi-Takahashi; Yoshito Tsushima
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

2.  Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach.

Authors:  Jasmine Naru; Ritu Aggarwal; Usha Singh; Ashok Kumar Mohanty; Deepak Bansal; Navdeep Mangat; Nandita Kakkar; Navneet Agnihotri
Journal:  Tumour Biol       Date:  2016-08-03

3.  In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line.

Authors:  Rohini M Nair; Murali Ms Balla; Imran Khan; Ravi Kiran Reddy Kalathur; Paturu Kondaiah; Geeta K Vemuganti
Journal:  BMC Cancer       Date:  2017-11-21       Impact factor: 4.430

Review 4.  CD133: holy of grail of neuro-oncology or promiscuous red-herring?

Authors:  L K Donovan; G J Pilkington
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

5.  RB116: an RB1+ retinoblastoma cell line expressing primitive markers.

Authors:  Anthony Bejjani; Mee Rim Choi; Linda Cassidy; David W Collins; Joan M O'Brien; Tim Murray; Bruce R Ksander; Gail M Seigel
Journal:  Mol Vis       Date:  2012-11-29       Impact factor: 2.367

6.  Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells.

Authors:  Hongbo Zhang; Weidong Liu; Xiangling Feng; Lei Wang; Xingjun Jiang; Dingyang Liu; Lihua Zhang; Bin Zhu; Wen Zhou; Wenting Jia; Guifei Li; Caiping Ren
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

7.  Downregulation of PAX6 by shRNA inhibits proliferation and cell cycle progression of human non-small cell lung cancer cell lines.

Authors:  Xiaoting Zhao; Wentao Yue; Lina Zhang; Li Ma; Wenyun Jia; Zhe Qian; Chunyan Zhang; Yue Wang
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

8.  Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.

Authors:  Quan Cheng; Xiaoqiang Ma; Hui Cao; Zigui Chen; Xin Wan; Rui Chen; Renjun Peng; Jun Huang; Bing Jiang
Journal:  Mol Med Rep       Date:  2016-12-27       Impact factor: 2.952

Review 9.  Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.

Authors:  Jee-Heun Kim; So-Yeon Park; Youngsoo Jun; Ji-Young Kim; Jeong-Seok Nam
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.